Abstract: Disclosed are compositions for eliciting anti-SARS-CoV-2 immune responses in subjects. In some embodiments, the compositions include one or more SARS-CoV-2 antigens and one or more PEGylated liposomal adjuvants, wherein at least one of the PEGylated liposomal adjuvants includes a cholesterol, a non-PEGylated neutral lipid, and a PEGylated lipid. Also provided are methods for using the presently disclosed compositions for stimulating anti-SARS-CoV-2 immune responses, for inducing anti-SARS-CoV-2 Th1 responses, for stimulating systemic immune responses and/or mucosal immune responses, for inducing anti-SARS-CoV-2 IgA responses, for reducing SARS-CoV-2-induced lung injuries, and for inducing anti-SARS-CoV-2 neutralizing antibodies in subjects in need thereof.

Abstract: A method and apparatus for collating, correlating and redistributing information about the use of proprietary products including copyrighted works and licensed software products, at various computer sites. The system consolidates information (originally captured by other systems) by time period, such as day, week or month, about which proprietary products are installed at each computer site, as well as to what particulars of use are relevant. This may include the number of invocations of various software products, the number of logons, the number of concurrent users, as well as other usage metrics. The information is sorted by vendor or copyright owner, so that the information about all of the proprietary products licensed from a particular vendor can be periodically sent to that vendor, automatically, or in response to prompting by vendors or from within the central computer system.